Common use of Voting of Deposited Shares Clause in Contracts

Voting of Deposited Shares. 20 SECTION 4.8. Tender and Exchange Offers; Redemption, Replacement or Cancellation of Deposited Securities. 21 SECTION 4.9. Reports. 22 SECTION 4.10. Lists of Owners. 23 SECTION 4.11. Withholding. 23 ARTICLE 5. THE DEPOSITARY, THE CUSTODIANS AND THE COMPANY 23 SECTION 5.1. Maintenance of Office and Register by the Depositary. 23 SECTION 5.2. Prevention or Delay of Performance by the Company or the Depositary. 24 SECTION 5.3. Obligations of the Depositary and the Company. 25 SECTION 5.4. Resignation and Removal of the Depositary. 26 SECTION 5.5. The Custodians. 27 SECTION 5.6. Notices and Reports. 27 SECTION 5.7. Distribution of Additional Shares, Rights, etc. 28 SECTION 5.8. Indemnification. 28 SECTION 5.9. Charges of Depositary. 29 SECTION 5.10. Retention of Depositary Documents. 30 SECTION 5.11. Exclusivity. 30 SECTION 5.12. Information for Regulatory Compliance. 31 ARTICLE 6. AMENDMENT AND TERMINATION 31 SECTION 6.1. Amendment. 31 SECTION 6.2. Termination. 31 ARTICLE 7. MISCELLANEOUS 33 SECTION 7.1. Counterparts; Signatures; Delivery. 33 SECTION 7.2. No Third Party Beneficiaries. 33 SECTION 7.3. Severability. 33 SECTION 7.4. Owners and Holders as Parties; Binding Effect. 33 SECTION 7.5. Notices. 33 SECTION 7.6. Appointment of Agent for Service of Process; Submission to Jurisdiction; Jury Trial Waiver. 34 SECTION 7.7. Waiver of Immunities. 35 SECTION 7.8. Governing Law. 36 DEPOSIT AGREEMENT dated as of __________, 2022 among TC BIOPHARM (HOLDINGS) PLC, a company incorporated under the laws of Scotland (herein called the Company), THE BANK OF NEW YORK MELLON, a New York banking corporation (herein called the Depositary), and all Owners and Holders (each as hereinafter defined) from time to time of American Depositary Shares issued hereunder.

Voting of Deposited Shares. 20 SECTION 4.8. Tender and Exchange Offers; Redemption, Replacement or Cancellation of Deposited Securities. 21 20 SECTION 4.9. Reports. 22 SECTION 4.10. Lists of Owners. 23 22 SECTION 4.11. Withholding. 23 22 ARTICLE 5. THE DEPOSITARY, THE CUSTODIANS AND THE COMPANY 23 SECTION 5.1. Maintenance of Office and Register by the Depositary. 23 SECTION 5.2. Prevention or Delay of Performance by the Company or the Depositary. 24 SECTION 5.3. Obligations of the Depositary and the Company. 25 SECTION 5.4. Resignation and Removal of the Depositary. 26 SECTION 5.5. The Custodians. 27 SECTION 5.6. Notices and Reports. 27 SECTION 5.7. Distribution of Additional Shares, Rights, etc. 28 SECTION 5.8. Indemnification. 28 SECTION 5.9. Charges of Depositary. 29 SECTION 5.10. Retention of Depositary Documents. 30 SECTION 5.11. Exclusivity. 30 SECTION 5.12. Information for Regulatory Compliance. 31 30 ARTICLE 6. AMENDMENT AND TERMINATION 31 30 SECTION 6.1. Amendment. 31 30 SECTION 6.2. Termination. 31 ARTICLE 7. MISCELLANEOUS 33 32 SECTION 7.1. Counterparts; Signatures; Delivery. 33 32 SECTION 7.2. No Third Party Beneficiaries. 33 32 SECTION 7.3. Severability. 33 SECTION 7.4. Owners and Holders as Parties; Binding Effect. 33 SECTION 7.5. Notices. 33 SECTION 7.6. Appointment of Agent for Service of Process; Submission to Jurisdiction; Jury Trial Waiver. 34 SECTION 7.7. Waiver of Immunities. 35 SECTION 7.8. Governing Law. 36 35 DEPOSIT AGREEMENT dated as of __________, 2022 2021 among TC BIOPHARM (HOLDINGS) PLCDAIMLER TRUCK HOLDING AG, a company incorporated under the laws of Scotland the Federal Republic of Germany (herein called the Company), THE BANK OF NEW YORK MELLON, a New York banking corporation (herein called the Depositary), and all Owners and Holders (each as hereinafter defined) from time to time of American Depositary Shares issued hereunder.

Voting of Deposited Shares. 20 SECTION 4.8. Tender and Exchange Offers; Redemption, Replacement or Cancellation of Deposited Securities. 21 SECTION 4.9. Reports. 22 SECTION 4.10. Lists of Owners. 23 22 SECTION 4.11. Withholding. 23 ARTICLE 5. THE DEPOSITARY, THE CUSTODIANS AND THE COMPANY 23 SECTION 5.1. Maintenance of Office and Register by the Depositary. 23 SECTION 5.2. Prevention or Delay of Performance by the Company or the Depositary. 24 SECTION 5.3. Obligations of the Depositary and the Company. 25 SECTION 5.4. Resignation and Removal of the Depositary. 26 SECTION 5.5. The Custodians. 27 SECTION 5.6. Notices and Reports. 27 SECTION 5.7. Distribution of Additional Shares, Rights, etc. 28 SECTION 5.8. Indemnification. 28 SECTION 5.9. Charges of Depositary. 29 SECTION 5.10. Retention of Depositary Documents. 30 SECTION 5.11. Exclusivity. 30 SECTION 5.12. Information for Regulatory Compliance. 31 30 ARTICLE 6. AMENDMENT AND TERMINATION 31 30 SECTION 6.1. Amendment. 31 30 SECTION 6.2. Termination. 31 ARTICLE 7. MISCELLANEOUS 33 32 SECTION 7.1. Counterparts; Signatures; Delivery. 33 32 SECTION 7.2. No Third Party Beneficiaries. 33 32 SECTION 7.3. Severability. 33 32 SECTION 7.4. Owners and Holders as Parties; Binding Effect. 33 SECTION 7.5. Notices. 33 SECTION 7.6. Appointment of Agent for Service of Process; Submission to Jurisdiction; Jury Trial Waiver. 34 SECTION 7.7. Waiver of Immunities. 35 SECTION 7.8. Governing Law. 36 35 AMENDED AND RESTATED DEPOSIT AGREEMENT dated as of __________, 2022 2021 among TC BIOPHARM (HOLDINGS) PLCHANNOVER ▇▇▇▇ ▇▇, a company incorporated under the laws of Scotland the Federal Republic of Germany (herein called the Company), THE BANK OF NEW YORK MELLON, a New York banking corporation (herein called the Depositary), and all Owners and Holders (each as hereinafter defined) from time to time of American Depositary Shares issued hereunder.